Markets and supply
New editionUK pharmaceutical market report 2026
The UK pharmaceutical market mapped: how it is structured, how medicines are priced and reimbursed, and where growth and pressure are coming from.
From £349
Generics and biosimilars: market outlook
How the UK generics and biosimilars markets work, who competes in them, and what drives pricing, switching and supply.
- Format
- PDF, approx. 55 pages
- Edition
- 2026 edition
- Delivery
- Download as soon as your payment arrives
This is a digital research report. It doesn't promote or supply any medicine, and nothing in it is medical, clinical, legal or investment advice.
What's included
- Segment structure and the main competitors
- Price dynamics and the drivers behind them
- Biosimilar adoption: policy, prescribing and switching
- Patent and exclusivity expiries to watch
- Supply risks for low-margin products
- Full reference library (RIS and BibTeX)
About this pack
Generic and biosimilar medicines account for most of the prescriptions dispensed in the UK. This outlook explains how those markets are structured, how competition and price pressure play out, and what that means for suppliers, wholesalers and buyers.
It is written for commercial, strategy and investor teams who need a sourced view of the segment.
Scope and sources
UK market. Published prescribing and spend data, company disclosures, regulator and NHS guidance.
More markets and supply
Markets and supply
Medicines supply chain and shortages briefing
Why medicines go short, how the UK supply chain is organised, and what manufacturers, wholesalers and pharmacies are doing about it.
From £199